Dynavax Technologies Corp (NASDAQ:DVAX)

24.92
BATS BZX Real-Time Price
As of 12:02pm ET
 -0.59 / -2.31%
Today’s Change
13.10
Today|||52-Week Range
26.89
+47.81%
Year-to-Date

Today’s Trading

Previous close25.51
Today’s open25.25
Day’s range24.50 - 25.39
Volume312,878
Average volume (3 months)391,024
Market cap$747.5M
Dividend yield--
Data as of 11:47am ET, 07/07/2015

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)-10.69%
Earnings growth (next 5 years)--
Revenue growth (last year)-1.95%
P/E ratioNM
Price/Sales40.18
Price/Book6.68

Competitors

 Today’s
change
Today’s
% change
RVNCRevance Therapeutics...-0.84-2.66%
SCMPSucampo Pharmaceutic...-0.04-0.23%
NWBONorthwest Biotherape...-0.03-0.30%
AMPHAmphastar Pharmaceut...-0.18-1.04%
Data as of 12:01pm ET, 07/07/2015

Financials

Next reporting dateJuly 22, 2015
EPS forecast (this quarter)-$0.98
Annual revenue (last year)$11.0M
Annual profit (last year)-$90.7M
Net profit margin-822.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers